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A discussion of the particulars leading to the eradication of 
smallpox is pertinent to both investigators and the public as the 
clamor for more “breakthroughs” intensifies. The rational allo- 
cation of biomedical research funds is increasingly threatened 
by disease-advocacy groups and congressional earmarking. 
An overly simplistic view of how advances truly occur promises 
only to stunt the growth of researchers and research areas not 
capable of immediate great breakthroughs. The authors review 
the contributions of Jenner and his countless predecessors to 
give a more accurate account of how “overnight medical break- 
throughs” truly occur-through years of work conducted by 
many people, often across several continents. 
In the public eye, few achievements are regarded with such 
excitement and awe as the medical breakthrough. Develop- 
ments such as the discovery of penicillin and the eradication 
of polio and smallpox have each become a great story built 
around a singular hero. Edward Jenner, for example, is cred- 
ited with discovering a means of safely conferring immunity to 
smallpox. The success of vaccination and subsequent eradi- 
cation of this disease elevated Jenner to a status in medical his- 
tory that is rivaled by few. 
However, the story of the eradication of smallpox does not 
start or end with the work of Jenner. Men such as Benjamin 
Jesty and Reverend Cotton Mather as well as unnamed physi- 
cians from tenth century China to eighteenth century Turkey 
also made critical contributions to the crowning achievement. 
Inoculation to prevent smallpox was commonplace in Europe 
for generations prior to Jenner’s work. Jenner himself was inoc- 
ulated as a child. In fact, vaccination with cowpox matter was 
documented in England over 20 years prior to Jenner’s work. 
The authors’ review of primary and secondary sources indi- 
cates that although Jenner’s contribution was significant, it was 
only one of many. It is extremely rare that a single individual or 
experiment generates a quantum leap in understanding; this 
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“lone genius” paradigm is potentially injurious to the research 
process. Wildly unrealistic expectations can only yield unsuc- 
cessful scientific investigation, but small steps by investigators 
supported by an informed public can build toward a giant leap, 
as the story of smallpox eradication clearly demonstrates. 
Int J Infect Dis 1998; 3:54-60. 
“.. in science credit goes to the man who con- 
vinces the world, not the man to whom the idea 
first OCCUTS.” 
Francis Galton 
Major scientific advances often come to be associated 
with a single researcher, such as Salk or Fleming, who is 
considered responsible for the “breakthrough.” However, 
actual examples of the lone genius phenomenon, in 
which an investigator single-handedly resolves a large 
problem, are few and far between. Much more commonly, 
developments represent the culmination of decades, if 
not centuries of work, conducted by hundreds of per- 
sons, complete with false starts, wild claims, and bitter 
rivalries. The breakthrough is really the latest in a series 
of small incremental advances, perhaps the one that has 
finally reached clinical relevance.Yet once a breakthrough 
is proclaimed, and the attendant hero identified, the work 
of the many others falls into distant shadow, far away 
from the adoring view of the public. 
This phenomenon is particularly important to con- 
sider now, as the sciences and scientific funding come 
under closer scrutiny. Disease-specific interest groups 
have had great success swaying public opinion, and 
research dollars, in their favor. In this environment, it is 
increasingly important to convey an accurate percep- 
tion of how successful biomedical research occurs. The 
public is enamored with the idea of the “breakthrough”; 
a search for this word in the Nexus database yielded 
1096 media citings over the past 2 years. A climate of 
unrealistic expectations by patients and the general pub- 
lic alike has developed. As such, research that does not 
overtly go for the “home run” may be hampered and 
even endangered. 
In this light, it is instructive to consider the break- 
through work of Edward Jenner, who is broadly credited 
for developing the vaccine that ultimately led to the erad- 
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ication of smallpox. As such, this is perhaps the greatest 
public health achievement recorded; Jenner’s stature as 
a scientist and benefactor of mankind is surpassed by 
few. But the history of smallpox prevention did not begin 
or end with Jenner (Iable 1). Indeed, effective inoculation 
against smallpox had gone on for centuries before his 
time, across many continents, incorporating varying 
approaches. One could even suggest that control of small- 
pox would have occurred had Edward Jenner never been 
born.Yet 200 years later, Jenner is the individual uniquely 
identified not only with smallpox vaccination but with 
the development of vaccination in general. 
Appreciation of what Jenner did and did not achieve 
is revealing for its applicability to the current races for 
medical breakthroughs in diseases such as cancer and 
acquired immunodeficiency syndrome (AIDS). The small- 
pox story is one of many heroes, each contributing a cru- 
cial element to the crowning achievement-the 
eradication of smallpox. Reviewing their historic roles is 
important for understanding the collaborative nature of 
research and tempering current expectations of 
researchers toiling to improve the lot of those with AIDS, 
cancer. and other diseases. 
EARLY INOCULATLON 
Early in recorded history, a critical observation was 
made-people who survived smallpox were immune to 
subsequent infections with the disease. As early as 430 
B.C,, survivors of smallpox were called upon to nurse 
the afflicted.‘x2 In the 10th century, the Chinese endeav- 
ored to transfer the infection to susceptible individuals 
with the goal of rendering them immune. They observed 
that “. . .the opening of pustules of one who has the small 
pox ripe upon them and drying up the Matter with a lit- 
tle Cotton... and afterwards put it up the nostrils of 
those they would infect” could transmit the virus and 
sometimes immunity.3~4 The Chinese text known as the 
Great Herbal of 1597 described an interesting alternative, 
which conjured images of modalities practiced years 
later. It suggested placement of “. ..powdered cow 
ice.. .into the nose of a child.“j The substance “cow ice” 
was not characterized. 
In India, it was noted that the case:fatality rate was 
lower in some epidemics than in others, probably owing 
to variation in virulence of the virus. However, infection 
during any epidemic still conferred lasting protection. It 
is believed that the Indian population exploited this 
observation as early as the 17th or 18th century.6z7 Dur- 
ing the “milder disease” outbreaks, pox-laden blankets 
were collected and susceptible children were wrapped 
in them with the intention of transmitting mild disease.6.7 
Another means of transmitting smallpox from per- 
son to person is referred to as inoculation, derived from 
the Latin hoc&are, meaning “to graft.” The terms inocu- 
lation and variolation, often used interchangeably, refer 
to the subcutaneous instillation of smallpox virus into 
nonimmune individuals. The inoculator utilized “. . a 
lancet wet with fresh matter taken from a ripe pustule 
of some person who has had a favorable kind of small- 
pox.. .to make an incision in the forearm of a child.“’ A 
local skin lesion would usually arise after 3 days and 
develop into a large, erythematous pustular lesion with 
satellite lesions over the next 4 or 5 days. Fever and con- 
stitutional symptoms would often accompany these 
lesions. 
Table 1. Important Dates in the History of Smallpox and Its Demise 
Date Event 
430 B.C. Thucydides chronicles Athens besieged by plague, possibly smallpox 
300 A.D. Earliest reported Chinese description of smallpox 
679 A.D. Earliest specific European references to smallpox epidemic 
Tenth century Chinese physicians inoculate smallpox intranasally to bolster immunity 
1701 Chinese practice of subcutaneous inoculation relayed to Royal Society; generates meager interest 
1716 Lady Mary Wortley Montagu witnesses inoculation while living in Turkey; has her children inoculated 
1721 Lady Montagu introduces inoculation in England; generates interest among upper class, but well-publicized early fatalities 
sharply limit growth 
1721 
1757 
1774 
1775 
1796 
1798 
1800 
1880 
1967 
1977 
1979 
Smallpox epidemic strikes Boston; Cotton Mather initiates controversial inoculation program 
Edward Jenner is inoculated (8 years old) 
Benjamin Jesty vaccinates his children with cowpox, and subsequently confirms their immunity by exposing them to smallpox 
George Washington orders all troops inoculated 
Edward Jenner vaccinates James Phipps with cowpox matter 
Jenner publishes his findings in “An Inquiry into the Causes and Effects of Variolae Vacciniae.” 
Waterhouse uses Jenner vaccine in the United States 
Pasteur initiates anthrax, rabies vaccines 
World Health Organization begins global initiative for the eradication of smallpox 
Ali Mao Malin is last human to contract naturally acquired smallpox 
WHO’s Global Commission for the Certification of Smallpox Eradication decrees smallpox has been eradicated 
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The practice of inoculation seems to have arisen 
independently when the people of various countries 
were faced with the threat of an epidemic. It is likely 
that inoculation had been practiced in Africa, India, and 
China prior to the seventeenth century.‘-l3 In India, 
members of the Brahman caste performed inoculation 
in conjunction with a religious cult of the smallpox 
deity.lO,il The “. . .priests traversed the country in the 
spring of every year and the virus was introduced by 
scarification in the arm.. .moistened with the water of 
the Ganges.“” 
Inoculation was not without its attendant risks, how- 
ever. There were concerns that recipients might develop 
disseminated smallpox and spread it to others.‘*,15 Trans- 
mission of other diseases, such as syphilis, via the blood- 
borne route also was a concern.’ 
INOCULATION IN EIGHTEENTH 
CENTURY EUROPE 
Eighteenth century Europeans were eager to learn 
about and adopt innovative ideas, especially from other 
cultures.’ Although the earliest recorded use of vario- 
lation in Europe was in seventeenth century Denmark, 
it was in Turkey that the influential minds of Europe 
first witnessed inoculation and eventually recom- 
mended its use throughout Europe.2 The Turks attrib- 
uted this innovation to the Circassians, “...whose 
women were reported to be very beautiful and.. sold 
for slaves by the poorer sort.. .(it was thought) neces- 
sary that all their females should have the small pox in 
their infancy because the distemper can spoil a face at 
any time, and the expense of a polite education 
might.. . .be thrown away.” l6 
The idea was presented to the Royal Society of Lon- 
don in 1714, when the physicians Jacob Pylarini and 
Emanuale Timoni independently sent letters from Con- 
stantinople.13,14 The presentation was greeted with little 
more than a passing interest, however, as London physi- 
cians were wary of risking their reputations on such an 
unconventional idea.‘* 
It would be 20 years before inoculation was tested 
in England. Lady Mary Wortley Montagu (1689-1762) 
lived in Turkey with her husband, the ambassador Edward 
Wortley Montagu.‘* It was there that Lady Montagu first 
witnessed inoculation, in 1716, and subsequently had her 
son inoculated. It is thought that her dedication to pre- 
venting the disease grew from the fact that her own once 
beautiful face had been disfigured by smallpox.3~17 Two 
years later, having returned to England, Lady Montagu had 
her daughter inoculated during a smallpox epidemic, 
under the scrutiny of the Royal Society’s Physicians.13 
The inoculation was considered successful when the 
child developed a limited number of lesions and did not 
contract overwhelming disease. 
Hans Sloane, physician to the king and prominent 
member of the Royal Society, recognized the significance 
of this experience and played a major role in promoting 
the subsequent study of the technique.* Under the direc- 
tion of Sloane, the procedure was tested on six con- 
demned prisoners who were promised amnesty if they 
survived.l* They all survived; one of them was even 
exposed to patients with active smallpox to demonstrate 
immunity. After seeing 10 orphans in St. James parish suc- 
cessfully inoculated, the Princess of Wales had her own 
two children inoculated.2 Although this and many other 
early inoculations were apparently successful, reports of 
sporadic inoculation-related deaths sharply limited accep- 
tance of the practice.13,1s 
THE NEW WORLD 
Under the guidance of Dr. Zabdiel Boylston (1679- 1766) 
and the Reverend Cotton Mather (1663-1728) variola- 
tion caught on much more rapidly in the colonies. Mather, 
a venerable leader of the Puritan church, is probably bet- 
ter remembered for compounding the hysteria sur- 
rounding the notorious Salem, Massachusetts, witchcraft 
trials. i9 
A graduate of Harvard College, Mather was extremely 
interested in science and medicine.2o In 1706, he learned 
of variolation from Onesimus, a slave who had been inoc- 
ulated in Africa as a child.9 Several years later, the ever- 
curious Mather read Timoni’s reports on the inoculation 
experience in Constantinople in the Royal Society’s Philo- 
sophic Transactions. The Reverend later wrote a letter to 
Dr. John Woodward (1665-1728) of the Royal Society, 
stating that if his community were threatened by small- 
pox, he would ask the local physicians to introduce a 
program of inoculation.l~zO 
In 1721, a ship carried persons sick with smallpox 
into Boston from the West Indies, starting an epidemic 
that was to become Boston’s worst in the eighteenth cen- 
tury. As he had planned, Mather wrote a “cautious and 
appeasing letter, which contained abstracts of the Timoni 
and Pylarini articles and urged...Boston physicians to 
practice variolation immediately? l4 
Boylston was the only physician Cotton Mather was 
able to persuade to initiate an inoculation program. They 
began inoculating volunteers throughout Boston, trans- 
ferring inoculum from the lesions of infected individuals 
to incisions on the arms of susceptible people. Boylston’s 
colleagues in the medical community spoke against this 
practice on both religious and medical grounds. Boston’s 
most prominent physicians expressed concern about 
inoculation contributing to spread rather than contain- 
ment of the disease, referring to reports of inoculation- 
related deaths from Europe. They also stated that it was 
not man’s place to interfere with the Lord’s “providence” 
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in these matters.20 Interestingly, it was the leading cleri- 
cal figures of the city who spoke out in defense of Boyl- 
ston and the practice of inoculation. They rallied around 
this medical innovation, stating that it was no more sac- 
rilegious than any other invasive medical procedure. The 
physicians took their struggle to the town’s governing 
body, the Selectmen. Dubious about the idea of inten- 
tionally exposing citizens to a potentially fatal disease, 
they reprimanded Boylston and proceeded to outlaw the 
procedure.‘O 
With Mather’s support, Boylston worked in contempt 
of the Selectman and continued his inoculation practice. 
As the disease spread, however, so did the controversy 
surrounding Mather. At the height of the epidemic, a 
bomb was thrown into his home.20 Mather sought to 
defend the practice in scientific terms. However, many 
of the earliest reports about inoculation were published 
by the practitioners themselves, who had a financial stake 
in the matter.21 
To make their point, Mather and Boylston used a sta- 
tistical approach to compare the mortality of smallpox 
infection contracted naturally with that contracted by 
inoculation. This may have been the first time that 
comparative analysis was used to examine a medical inter- 
vention. During the great epidemic of 1721, approxi- 
mately half of Boston’s 12,000 citizens contracted 
smallpox (5889 cases). The case:fatality rate was 14%. In 
contrast, Boylston and Mather reported a mortality rate 
among inoculated individuals of approximately 2% (6/300 
patients).z0 Assuming that all susceptible people in Boston 
had contracted the disease, they calculated that a manda- 
tory inoculation program could have reduced the fatality 
rate from 14% to 2%, saving 726 lives. In addition, small- 
pox acquired through inoculation was noted to be much 
less severe than naturally acquired disease. 
Subsequent reports confirmed that the mortality rate 
of inoculation was not insignificant-approximately 
2%.22,23 Throughout the colonies, many prominent figures 
continued to criticize inoculation and its practitioners 
harshly on religious grounds as well as scientific. Edmund 
Massey’s 1730 publication, ‘A Sermon against the Dan- 
gerous and Sinful Practice of Inoculation,” contains insight 
into the thinking of the time.25 He quoted Job 2:7, “So 
went Satan forth from the presence of the Lord, and 
smote Job with sore boils.. .” Massey felt this action was 
analogous to inoculation, and went on to implicate Satan 
as the first practitioner of inoculation.z4 
Massey argued that Job had achieved spiritual enlight- 
enment by enduring the trials of his suffering. He con- 
tinued,“Men cannot be sure of themselves until they have 
been proved.. .diseases are sent, if not for the trial of our 
faith, then for the punishment of our sins.. . . There is no 
thing so universally dreaded, as the disease which this 
strange method of practice pretends to exclude. But.. .the 
fear of it is a happy restraint upon many people.. .to keep 
themselves in temperance and sobriety.“** 
Word of the Boston Experiment Spreads 
The adoption of variolation throughout Europe can be 
directly traced to the efforts of Cotton Mather during the 
Boston smallpox epidemic of 172 1. Although British 
physicians had been loathe to inoculate after the well- 
publicized demise of some recipients, Mather and Boyl- 
ston’s data were influential. Inoculation was subsequently 
adopted in England, and it was later said that without the 
New England evidence the practice of inoculation would 
not have been reinstituted.z0 The idea of inoculation 
spread from England throughout Western Europe. 
In 1757, an S-year-old boy was inoculated in Glouces 
ter; he was one of thousands inoculated that year. The 
procedure was effective, as he developed a mild case of 
smallpox and was subsequently immune to the disease. 
His name was Edward Jenner.’ 
By the end of the eighteenth century, there were 
many practitioners of inoculation in Europe, and this 
likely decreased morbidity and mortality considerably. In 
addition, the concept of bolstering immunity to prevent 
the spread of disease helped to lay a foundation that 
would greatly facilitate the subsequent adoption of 
vaccination. l 
VACCINATION: A NEW IDEA? 
Cowpox is a self-limited, pastoral disease contracted via 
direct contact with lesions on the cow. People who con- 
tracted cowpox were noted to be immune to smallpox. 
It is impossible to determine when this protective phe- 
nomenon was first recognized, but a statement issued by 
the Jennerian Society in 1805 indicated that it was the 
“ . ..common opinion of the country ever since (the 
1750s). . .that persons who had gone through the Cow 
Pox naturally.. .were insusceptible of the Small Pox.“” In 
other parts of the world, however, this phenomenon was 
recognized far earlier. It has been described that certain 
tribes of Indian shepherds, for example, were convinced 
of the protective effect of cowpox “. .since the earliest 
recollection of manPI 
The first man credited for applying this hypothesis 
to clinical practice was a farmer named Benjamin Jesty. 
In 1774, Jesty’s community of Downshay was confronted 
with reports of smallpox in the area. Jesty noticed that 
two of his milkmaids who had previously suffered cow- 
pox did not contract smallpox despite close contact with 
known patients. Since he had already suffered cowpox 
and believed that he also was immune, he decided to 
transmit cowpox to his family. A neighboring farmer, Mr. 
Elford of Chittenhall, had several affected cows, which 
Jesty used to vaccinate his wife and two sons. In 1789, 
the Jesty boys were inoculated as part of a community- 
wide variolation program. They were the only children 
who did not acquire self-limited smallpox from this pro- 
cedure. Later, Jesty exposed his children to a smallpox 
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patient to prove their immunity He also vaccinated other 
people in the community.17 
On May 14,1796, Edward Jenner performed his first 
vaccination, introducing material from a cowpox vesicle 
on Sarah Nelmes, a milkmaid, into the arm of a boy named 
James Phipps. On July 1,1796, he inoculated the boy with 
smallpox. Smallpox did not develop.z5 In 1798, Jenner 
published “An Inquiry into the Causes and Effects of the 
Variolae Vacciniae,” a disease discovered in some of the 
western counties of England, particularly Gloucestershire, 
and known by the name of “The Cow Pox.“’ 
From a commercial perspective, the publication was 
an immediate success; however, from a scientific per- 
spective it initiated a lengthy and vigorous debate. Jenner 
believed in vaccination, a term he coined, and was will- 
ing to dedicate his career and his fortune to promoting 
its use. In 1798, he journeyed to London to convince his 
colleagues of the vaccine’s ability to confer immunity 
without the attendant risk of disseminated disease or sys- 
temic systems. Many prominent physicians opposed this 
practice. Professional jealousy, financial considerations, 
and apprehension about risking their reputations by per- 
forming untested procedures all played a role.l* 
Despite the objections of the medical establishment, 
vaccination rapidly became more widespread. However, 
it was reported that over two-thirds of recipients expe- 
rienced generalized eruptions, in marked contrast to Jen- 
ner’s early reports of cowpox vaccination. Jenner 
attributed this phenomenon to contamination of lymph, 
the substance used for vaccination, with smallpox virus.14 
Lymph was propagated by extracting material from 
a vaccinated individual’s pustule to use on subsequent 
patients. This arm-to-arm passage was periodically sup- 
plemented with cowpox material whenever an active 
case of this rare disease was discovered. Jenner used and 
distributed vaccine from his original stock until the 
1840s. It is not clear if any action was taken to minimize 
use of contaminated lymph; in fact some documents 
described vaccination with Jenner’s lymph as having a 
quantity of pustules and mortality rate similar to that seen 
previously in variolation. 15az6 
Over 100,000 people were vaccinated by 1801, and 
Jenner subsequently petitioned the House of Parliament 
for recognition of his claim to discovery of vaccination 
and recompense. The House of Commons, after hearing 
the results of a special committee’s inquiry, issued a state- 
ment that “The whole of oral depositions, as well as the 
written documents from abroad, are uniform and decisive 
in favor of Dr. Jenner’s claim to Originality.“27 Jenner was 
awarded grants totaling &30,000.’ 
During the committee’s deliberations, it was pointed 
out by some that inoculation had been practiced “. . in 
some dairies previous to Dr. Jenner’s experiments:’ In an 
1805 publication, Jenner’s nephew George replied that 
“. . if a person makes a discovery calculated to ameliorate 
the sufferings of his fellow creatures, and withholds its 
benefits from the world, certainly he cannot claim that 
reward which would otherwise be due his merit.“28 
Later that year, Benjamin Jesty petitioned the newly 
formed Jennerian Society for recognition of his contri- 
bution. After hearing his evidence, the Society recognized 
Benjamin Jesty as the first person to “. .personally insti- 
tute. the vaccine pock inoculation,. (and) provide deci- 
sive proofs of the permanent anti-variolous effects of the 
Cow Pock.“l’ He was brought to London, where he sat for 
an official portrait and was given a nominal reward. Dis- 
liking London, Jesty returned to his farm a few days later. 
The first vaccination in the United States was per- 
formed in 1800 by Benjamin Waterhouse (1754-1846) 
on his son, Daniel.” Waterhouse then wrote to President 
Thomas Jefferson (1743-1826) and asked him to sponsor 
the distribution of vaccine to the southern states. Jeffer- 
son, who had been variolated himself at the age of 23 
years, had his family and neighbors vaccinated. He quickly 
became a fervent proponent of vaccination, and wrote a 
letter to Jenner thanking him for his work.14 Congress 
established the National Vaccine Agency, in 1813, and 
named Dr. James Smith (d. 1841) as its director. However, 
reports of vaccine contamination with smallpox, and con- 
cerns about the duration of its protective effect led Con- 
gress to eliminate funding for the Agency in 1822.‘” 
FURTHER DEVELOPMENTS IN VACCINATION 
Prominent philosophers, such as Robert Thomas Malthus 
(1766-1834) questioned the utility of smallpox preven- 
tion. He hailed the disease as an agent of population con- 
trol, particularly among the overcrowded lower class.30 
Antivaccination groups proliferated, but these vocal 
minorities were unable to halt the rapid adoption of the 
idea. By 182 1, vaccination was required by law in Bavaria, 
Norway, Sweden, and Denmark. In 1853, England ren- 
dered primary vaccination of infants compulsory, with a 
penalty of 20 shillings for noncompliance.31 
Although there was widespread use of vaccination in 
the early nineteenth century, the lymph being used was 
far from ideal. A questionable duration of immunity, con- 
tamination and decomposition of the lymph, and short- 
age of cowpox matter all plagued early practitioners. 
In spite of excellent compliance with vaccination in 
some European countries, pandemics occurred in 1824 
and 1837. These outbreaks were notable for an unusually 
high incidence of illness, albeit mild, in vaccinated adults. 
Acting on the hypothesis that vaccine-induced immunity 
wanes over years, several German teams instituted a 
mandatory revaccination program in the 1830s. Within a 
year of this initiative, a sustained decrease in the inci- 
dence of smallpox was realized.’ 
About 1850, a British physician named Cheyne added 
glycerol to cowpox lymph and found that it prevented 
decomposition without decreasing efficacy. The pro- 
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longed storage time enabled physicians to cease arm-to- ple of this; perhaps AIDS will be another. But we will have 
arm passage of vaccine, dramatically decreasing the poten- to wait and hope for progress, one step at a time. 
tial for contamination. The newer formulation of vaccine 
also enabled worldwide distribution for the first time, as 
the shelf-life no longer precluded long-distance shipping. REFERENCES 
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motion of vaccination changed the way medicine was 
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